-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to news from Ai Di Weixin on August 9, Ai Di Weixin's new crown DNA vaccine (INO-4800/pGX9501) has been approved to conduct clinical trials with inactivated vaccines to explore sequential immunization strategies
.
The trial uses the new crown DNA vaccine and the new crown inactivated vaccine to carry out a heterologous prime-boost (Heterologous prime-boost) sequential immunization program to explore the safety, humoral immune response and cells of subjects under each vaccination program Clinical indicators such as immune response level
.
Joint immunization with inactivated vaccine DNA vaccine for the new crown Kerr Lai Fu (CoronaVac), by the Beijing Sinovac Biotech Co.
, Ltd.
developed in Victoria
.
The product has been proven to have good safety and immunogenicity, has been approved for use in dozens of countries and regions around the world, and has been officially included in the World Health Organization's emergency use list
.